CR10261A - Formulaciones novedosas - Google Patents
Formulaciones novedosasInfo
- Publication number
- CR10261A CR10261A CR10261A CR10261A CR10261A CR 10261 A CR10261 A CR 10261A CR 10261 A CR10261 A CR 10261A CR 10261 A CR10261 A CR 10261A CR 10261 A CR10261 A CR 10261A
- Authority
- CR
- Costa Rica
- Prior art keywords
- formulations
- new formulations
- fpf
- variability
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78463406P | 2006-03-22 | 2006-03-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10261A true CR10261A (es) | 2008-11-26 |
Family
ID=38523271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10261A CR10261A (es) | 2006-03-22 | 2008-08-28 | Formulaciones novedosas |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2012797A2 (pt) |
JP (1) | JP2009530419A (pt) |
KR (1) | KR20080110854A (pt) |
CN (1) | CN101415428A (pt) |
AR (1) | AR060039A1 (pt) |
AU (1) | AU2007226899A1 (pt) |
BR (1) | BRPI0708798A2 (pt) |
CA (1) | CA2646236A1 (pt) |
CR (1) | CR10261A (pt) |
EA (1) | EA200801854A1 (pt) |
IL (1) | IL193723A0 (pt) |
MA (1) | MA30328B1 (pt) |
MX (1) | MX2008011967A (pt) |
NO (1) | NO20083760L (pt) |
PE (1) | PE20080124A1 (pt) |
TW (1) | TW200803870A (pt) |
WO (1) | WO2007109698A2 (pt) |
ZA (1) | ZA200807682B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2400950T3 (da) | 2009-02-26 | 2019-07-29 | Glaxo Group Ltd | Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2122261T3 (es) * | 1993-03-17 | 1998-12-16 | Minnesota Mining & Mfg | Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester. |
US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
AR032471A1 (es) * | 2000-08-05 | 2003-11-12 | Glaxo Group Ltd | Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter |
-
2007
- 2007-03-21 EP EP07758963A patent/EP2012797A2/en not_active Withdrawn
- 2007-03-21 EA EA200801854A patent/EA200801854A1/ru unknown
- 2007-03-21 WO PCT/US2007/064462 patent/WO2007109698A2/en active Application Filing
- 2007-03-21 CN CNA2007800098351A patent/CN101415428A/zh active Pending
- 2007-03-21 AR ARP070101155A patent/AR060039A1/es not_active Application Discontinuation
- 2007-03-21 AU AU2007226899A patent/AU2007226899A1/en not_active Abandoned
- 2007-03-21 MX MX2008011967A patent/MX2008011967A/es not_active Application Discontinuation
- 2007-03-21 PE PE2007000310A patent/PE20080124A1/es not_active Application Discontinuation
- 2007-03-21 CA CA002646236A patent/CA2646236A1/en not_active Abandoned
- 2007-03-21 BR BRPI0708798-5A patent/BRPI0708798A2/pt not_active IP Right Cessation
- 2007-03-21 KR KR1020087025825A patent/KR20080110854A/ko not_active Application Discontinuation
- 2007-03-21 TW TW096109797A patent/TW200803870A/zh unknown
- 2007-03-21 JP JP2009501708A patent/JP2009530419A/ja active Pending
-
2008
- 2008-08-27 IL IL193723A patent/IL193723A0/en unknown
- 2008-08-28 CR CR10261A patent/CR10261A/es not_active Application Discontinuation
- 2008-09-01 NO NO20083760A patent/NO20083760L/no not_active Application Discontinuation
- 2008-09-05 ZA ZA200807682A patent/ZA200807682B/xx unknown
- 2008-10-07 MA MA31274A patent/MA30328B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
KR20080110854A (ko) | 2008-12-19 |
MA30328B1 (fr) | 2009-04-01 |
CN101415428A (zh) | 2009-04-22 |
JP2009530419A (ja) | 2009-08-27 |
ZA200807682B (en) | 2009-11-25 |
MX2008011967A (es) | 2009-01-14 |
NO20083760L (no) | 2008-12-17 |
CA2646236A1 (en) | 2007-09-27 |
AU2007226899A1 (en) | 2007-09-27 |
PE20080124A1 (es) | 2008-04-21 |
EA200801854A1 (ru) | 2009-04-28 |
EP2012797A2 (en) | 2009-01-14 |
WO2007109698A2 (en) | 2007-09-27 |
BRPI0708798A2 (pt) | 2011-06-14 |
IL193723A0 (en) | 2009-08-03 |
WO2007109698A3 (en) | 2008-12-18 |
AR060039A1 (es) | 2008-05-21 |
TW200803870A (en) | 2008-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
BR112012007182A2 (pt) | uso de um material arrastado em dessecante, válvula de dosagem de inalador pressurizado de dose medida, sistema de recipiente fechado de inalador pressurizado de dose medida, e, método para estabilizar a massa de partícula fina (mpf) de uma formulação de droga de inalação | |
ECSP088403A (es) | Formulacion farmaceutica de absorción oral y su método de administracion | |
NZ588913A (en) | Liver cancer drug | |
MX2007008379A (es) | Metodos y composiciones para minimizar la acumulacion de insulina inhlable en los pulmones. | |
SG160364A1 (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
EA200801213A1 (ru) | Игла для прокалывания капсул с порошком для ингаляции | |
MX336225B (es) | Composiciones que comprenden sulfato de salbutamol. | |
UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
UA101652C2 (uk) | Композиція для інгаляції, що містить аклідиній для лікування астми та хронічного обструктивного захворювання легень | |
CR10112A (es) | Enmascaramiento del sabor de polvos. | |
GB2496799A (en) | A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders | |
BR112014008602A2 (pt) | composição farmacêutica, recipiente vedado, inalador de dosagem medida, métodos para o tratamento de um paciente que sofre ou provavelmente sofre de um distúrbio respiratório, e, método para fabricação de uma composição farmacêutica | |
PH12014502662A1 (en) | Novel dosage form and formulation of abediterol | |
BR112015026053A8 (pt) | composição farmacêutica, recipiente vedado, inalador dosimetrado, uso de um componente propelente, e, método para fabricação de uma composição farmacêutica | |
WO2012040228A3 (en) | Aerosol composition for administering drugs | |
CY1117596T1 (el) | Φαρμακευτικeς συνθeσεις αερολyματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης | |
MX2015015150A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
AR079000A1 (es) | Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas | |
MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
CR10261A (es) | Formulaciones novedosas | |
AR083893A1 (es) | Uso de una composicion farmaceutica que comprende (s) (3-(1-(1h-imidazol-4-il)etil)-2-metilfenil)metanol para preparar un medicamento topico de utilidad en la reduccion de la presion intraocular y articulo de manufactura correspondiente | |
MX2010007569A (es) | Productos farmaceuticos para inhalacion, sistemas y usos. | |
UA109530C2 (uk) | Композиції, способи та системи для доставки респіраторним шляхом двох чи більше активних агентів |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |